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Background: In EVEREST II RCT, MitraClip reduced mitral regurgitation (MR) severity safely but to a lesser degree than surgery. A premise of the 
trial was that a lower degree of MR reduction with MitraClip provides meaningful clinical benefit. Few data exist on the magnitude of MR reduction 
necessary to provide reverse left ventricular (LV) and left atrial (LA) remodeling in patients with severe MR.
Methods: 389 MitraClip patients (178 EVEREST II RCT, 211 High Risk Cohort) are included in this analysis. All had severe (3-4+) MR at enrollment. 
MR severity, LVEDV, LVESV, and LAV were measured by an independent echo core lab. A linear repeated measures model was developed and included 
effects of MR severity and time of measurement post-index procedure on longitudinal LV and LA volumes. Separate models were fit for functional (F) 
and degenerative (D) MR.
Results: Reduction of MR in both FMR and DMR was significantly associated with reduction in LVEDV, LVESV and LA volume. Fig. 1 shows 
relationship of reduction in MR to reduction in LVEDV in FMR and DMR (p<0.0001 in both). MR reduced to 1+ or 2+ was associated with significant 
LV remodeling. Greater reduction in MR was associated with greater reduction in LV and LA volumes.
Conclusions: This model systematically evaluates the effect of reduction in MR on LV and LA volumes without the confounding effects of 
sternotomy or cardiopulmonary bypass. Reduction of LV and LA volumes in FMR and DMR demonstrates the clinical benefit of reduction in MR 
severity following MitraClip therapy.
 
